PUMA BIOTECHNOLOGY, INC. — Director's Dealing 2017

Jun 1, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PUMA BIOTECHNOLOGY, INC. (PBYI)
CIK: 0001401667
Period of Report: 2017-05-31

Reporting Person: EYLER CHARLES R (SEE REMARKS)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-05-31	COMMON STOCK	A	21000	$0.00	Acquired	30680	Direct

Footnotes

F1: Represents Restricted Stock Units which vest in six substantially equal installments on each six-month anniversary of the Vesting Commencement Date of May 31, 2017, subject to the Reporting Person's continued service with the Issuer through the applicable vesting date.